Beroni Group Limited (OTCMKTS:BNIGF) (NSX:BTG) advises that it has entered into unsecured and interest free convertible loan agreements with two investors for an aggregate principal loan amount of US$291,545.
Beroni Group Limited (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, announced that its enhanced COVID-19 Antigen Rapid Test Kit - Colloidal Gold Method has been undergoing clinical trial in China, for eventual application to the National Medical Product Administration.
Beroni Group (OTCMKTS:BNIGF) (NSX:BTG) announced that it has received notification that its latest enhanced COVID-19 Antigen Rapid Test Kit has complied with the applicable essential requirements of the council directive 98/79/EEC in vitro diagnostics as amended.
Beroni Group Limited (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, today announced that its article has been accepted for publication and undergone full review in the FEBS Journal.